© 2024 ACCESS Forum
ACCESS Forum invites you to submit an abstract for presentation at the upcoming ACCESS Forum event in Austin, Texas!
ACCESS Forum is the first international community of market and patient access experts and professionals focused on shaping the Access Landscape—and solving the challenges facing Market and Patient Access globally.
The mission of ACCESS Forum is to be the global home and voice sharing best practices, shaping global policies, and driving innovation in access for health products, technologies, and services. Abstracts accepted will be a part of this center of excellence by disseminating scientific evidence for this shared value. In addition to being presented as either an oral or poster presentation at the conference, all accepted abstracts will be published in ACCESS Forum’s new journal.
ACCESS Forum is the first international community of market and patient access experts and professionals focused on shaping the Access Landscape—and solving the challenges facing Market and Patient Access globally.
The mission of ACCESS Forum is to be the global home and voice sharing best practices, shaping global policies, and driving innovation in access for health products, technologies, and services. Abstracts accepted will be a part of this center of excellence by disseminating scientific evidence for this shared value. In addition to being presented as either an oral or poster presentation at the conference, all accepted abstracts will be published in ACCESS Forum’s new journal.
Abstract submission deadline: 31 March 2025
Abstract decision date: 25 April 2025
Abstract decision date: 25 April 2025
- All submissions must be written in English.
- All submissions must not promote any product or service.
- Do not submit dublicate abstracts.
- Abstracts that have already been published in another journal are not allowed.
- Expenses associated with submission are the author's sole responsibility.
- Authors must disclose AI-assisted content when submitting.
- Submissioins have a maximum limit of 500 words, excluding title and author information
- Tables and graphs in abstracts are not allowed.
- Generic names of drugs and devices should be used instead of trade names.
- Optionally, submissions completed in Nested Knowledge may include a QR code to link the poster to its digital twin.
Submit your abstract via email as a Word document attachment to info@marketaccess.org. Please include all author name(s), affiliation(s), degree(s), and any conflicts of interest.
